{"database": "lobbying", "table": "lobbying_activities", "rows": [[2144440, "72a9eb6b-cde9-4816-9cbd-2e13e6286e63", "Q2", "EMANUEL & ASSOCIATES, INC. (FKA ADAM EMANUEL)", 13461, "DEFENDER PHARMACEUTICALS", 2018, "second_quarter", "HOM", "Pharmaceutical solutions against WMD trauma to the brain and new therapy for motion sickness", "Defense Threat Reduction Agency (DTRA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE", 12000, null, 0, 0, "2018-07-14T16:40:43.250000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2144440"], "units": {}, "query_ms": 16.57977094873786, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}